Barclays Maintains Underweight on XPLR Infr, Lowers Price Target to $6
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and lowers the price target from $7 to $6.
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and lowers the price target from $7 to $6.